You are here

breast cancer

Moving up the lines, AstraZeneca stakes another PhIII win for Lynparza as adjuvant breast cancer therapy

Endpoints

Wed, 02/17/21 - 11:21 am

clinical trials

BRCA-mutant breast cancer

AstraZeneca drops breast, prostate cancer programs in Q4 pipeline cull

Fierce Biotech

Thu, 02/11/21 - 10:34 am

prostate cancer

The year immuno-oncology could break into perioperative settings

EP Vantage

Tue, 01/26/21 - 12:00 am

immuno-oncology

perioperative breast cancer

Veru touts novel breast cancer treatment strategy as drug nears phase 3

Fierce Biotech

Thu, 01/21/21 - 11:27 pm

clinical trials

MacroGenics wins FDA approval of breast cancer drug

BioPharma Dive

Thu, 12/17/20 - 06:15 pm

Could Amgen's Xgeva boost immunotherapy in breast cancer?

Fierce Biotech

Mon, 12/14/20 - 10:37 am

SABCS: Novartis touts Kisqali's 5-year breast cancer survival, advantage over Pfizer's Ibrance

Fierce Pharma

Wed, 12/9/20 - 10:51 am

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor

Fierce Biotech

Sun, 10/25/20 - 11:28 pm

KSQ Therapeutics

PARP inhibitors

Ibrance trial failure dashes Pfizer’s growth hopes for the drug

Pharmaforum

Sun, 10/11/20 - 10:23 pm

Pfizer's breast cancer drug Ibrance fails late-stage study

Reuters

Fri, 10/9/20 - 10:58 am

clinical trials

InventisBio reels in $147M to push gout and breast cancer drugs along

Endpoints

Mon, 09/28/20 - 10:42 am

Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst

Fierce Pharma

Thu, 09/24/20 - 11:26 pm

Gilead Sciences

ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer

Fierce Pharma

Sun, 09/20/20 - 07:54 pm

ESMO: Novartis parses long-awaited survival data for breast cancer blockbuster hopeful Piqray

Fierce Pharma

Sat, 09/19/20 - 09:12 pm

Olema Oncology grabs $54M for breast cancer program

Fierce Biotech

Thu, 07/23/20 - 11:13 am

Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial

TheStreet.com

Tue, 06/16/20 - 10:52 am

clinical trials

Sanofi sharpens focus on bispecifics, and China, with Alphamab deal

Endpoints

Wed, 06/10/20 - 10:41 am

Alphamab Oncology

bispecific antibodies

Scientists Find A Switch To Turn Off A Gene That Causes Aggressive Breast Cancer

Forbes

Thu, 06/4/20 - 09:55 pm

Pfizer Shares Dipped Following Release of Phase III Palbociclib Study Data

BioSpace

Mon, 06/1/20 - 11:38 pm

AstraZeneca to unveil key data for cancer drugs at ASCO

Pharmaforum

Fri, 05/15/20 - 10:41 am

colorectal cancer

Pages